Dissemination of <it>Strongyloides stercoralis </it>in a patient with systemic lupus erythematosus after initiation of albendazole: a case report
<p>Abstract</p> <p>Introduction</p> <p><it>Strongyloides stercoralis </it>infection affects hundreds of millions of people worldwide. As immigration rates and international travel increase, so does the number of cases of strongyloidiasis in the United States...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-05-01
|
| Series: | Journal of Medical Case Reports |
| Online Access: | http://www.jmedicalcasereports.com/content/2/1/156 |
| _version_ | 1828466568987672576 |
|---|---|
| author | Hunter Catherine J Petrosyan Mikael Asch Morris |
| author_facet | Hunter Catherine J Petrosyan Mikael Asch Morris |
| author_sort | Hunter Catherine J |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Introduction</p> <p><it>Strongyloides stercoralis </it>infection affects hundreds of millions of people worldwide. As immigration rates and international travel increase, so does the number of cases of strongyloidiasis in the United States. Although described both in immigrant and in immunosuppressed populations, hyperinfection and dissemination of <it>S. stercoralis </it>following the initiation of antiparasitic medication is a previously unreported phenomenon.</p> <p>Case presentation</p> <p>Here we describe the case of a 38-year-old immunocompromised woman with systemic lupus erythematosus, who developed disseminated disease following treatment with albendazole (400 mg every 12 hours). Notably the patient was receiving oral prednisone (10 mg once daily), azathioprine (50 mg twice daily), and hydroxychloroquine (400 mg daily) at the time of hospitalization. The patient was subsequently treated successfully with ivermectin (200 mcg/kg daily).</p> <p>Conclusion</p> <p>The reader should be aware that dissemination of <it>S. stercoralis </it>can occur even after the initiation of antiparasitic medication.</p> |
| first_indexed | 2024-12-11T03:51:26Z |
| format | Article |
| id | doaj.art-ea0cbca720804c599614ae4fe842cf2b |
| institution | Directory Open Access Journal |
| issn | 1752-1947 |
| language | English |
| last_indexed | 2024-12-11T03:51:26Z |
| publishDate | 2008-05-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Medical Case Reports |
| spelling | doaj.art-ea0cbca720804c599614ae4fe842cf2b2022-12-22T01:21:53ZengBMCJournal of Medical Case Reports1752-19472008-05-012115610.1186/1752-1947-2-156Dissemination of <it>Strongyloides stercoralis </it>in a patient with systemic lupus erythematosus after initiation of albendazole: a case reportHunter Catherine JPetrosyan MikaelAsch Morris<p>Abstract</p> <p>Introduction</p> <p><it>Strongyloides stercoralis </it>infection affects hundreds of millions of people worldwide. As immigration rates and international travel increase, so does the number of cases of strongyloidiasis in the United States. Although described both in immigrant and in immunosuppressed populations, hyperinfection and dissemination of <it>S. stercoralis </it>following the initiation of antiparasitic medication is a previously unreported phenomenon.</p> <p>Case presentation</p> <p>Here we describe the case of a 38-year-old immunocompromised woman with systemic lupus erythematosus, who developed disseminated disease following treatment with albendazole (400 mg every 12 hours). Notably the patient was receiving oral prednisone (10 mg once daily), azathioprine (50 mg twice daily), and hydroxychloroquine (400 mg daily) at the time of hospitalization. The patient was subsequently treated successfully with ivermectin (200 mcg/kg daily).</p> <p>Conclusion</p> <p>The reader should be aware that dissemination of <it>S. stercoralis </it>can occur even after the initiation of antiparasitic medication.</p>http://www.jmedicalcasereports.com/content/2/1/156 |
| spellingShingle | Hunter Catherine J Petrosyan Mikael Asch Morris Dissemination of <it>Strongyloides stercoralis </it>in a patient with systemic lupus erythematosus after initiation of albendazole: a case report Journal of Medical Case Reports |
| title | Dissemination of <it>Strongyloides stercoralis </it>in a patient with systemic lupus erythematosus after initiation of albendazole: a case report |
| title_full | Dissemination of <it>Strongyloides stercoralis </it>in a patient with systemic lupus erythematosus after initiation of albendazole: a case report |
| title_fullStr | Dissemination of <it>Strongyloides stercoralis </it>in a patient with systemic lupus erythematosus after initiation of albendazole: a case report |
| title_full_unstemmed | Dissemination of <it>Strongyloides stercoralis </it>in a patient with systemic lupus erythematosus after initiation of albendazole: a case report |
| title_short | Dissemination of <it>Strongyloides stercoralis </it>in a patient with systemic lupus erythematosus after initiation of albendazole: a case report |
| title_sort | dissemination of it strongyloides stercoralis it in a patient with systemic lupus erythematosus after initiation of albendazole a case report |
| url | http://www.jmedicalcasereports.com/content/2/1/156 |
| work_keys_str_mv | AT huntercatherinej disseminationofitstrongyloidesstercoralisitinapatientwithsystemiclupuserythematosusafterinitiationofalbendazoleacasereport AT petrosyanmikael disseminationofitstrongyloidesstercoralisitinapatientwithsystemiclupuserythematosusafterinitiationofalbendazoleacasereport AT aschmorris disseminationofitstrongyloidesstercoralisitinapatientwithsystemiclupuserythematosusafterinitiationofalbendazoleacasereport |